These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 63315)

  • 1. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
    Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
    Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein and other tumor markers in relation to cancer of the breast.
    Zangerle PF; Thirion A; Hendrick JC; Franchimont P
    Antibiot Chemother (1971); 1978; 22():141-8. PubMed ID: 74972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum biochemical markers in lung cancer.
    Burt RW; Ratcliffe JG; Stack BH; Cuthbert J; Kennedy RS; Corker CS; Franchimont P; Spilg WG; Stimson WH
    Br J Cancer; 1978 May; 37(5):714-7. PubMed ID: 77672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
    Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
    J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
    Yoshimoto T; Higashino K; Hada T; Tamura S; Nakanishi K; Mitsunobu M; Uematsu K; Matsuoka T; Taketa K
    Cancer; 1987 Dec; 60(11):2744-50. PubMed ID: 2445464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA, AFP and other potential tumor markers.
    Zamcheck N; Pusztaszeri G
    CA Cancer J Clin; 1975; 25(4):204-14. PubMed ID: 48409
    [No Abstract]   [Full Text] [Related]  

  • 9. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
    Irie T; Watanabe H; Kawaoi A; Takeuchi J
    Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay.
    Shuster J; Freedman SO; Gold P
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):679-87. PubMed ID: 72501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofetal antigens in sacrococcygeal teratomas.
    Kuhajda FP; Taxy JB
    Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa.
    Hustin J
    Gynecol Obstet Invest; 1978; 9(1):3-15. PubMed ID: 81793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
    Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
    Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor antigens.
    Egan ML; Engvall E; Ruoslahti EI; Todd CW
    Cancer; 1977 Jul; 40(1 Suppl):458-66. PubMed ID: 69486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CEA serum level in patients with liver diseases].
    Lamerz R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1201-4. PubMed ID: 206044
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
    Bychkov V; Rothman M; Bardawil WA
    Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.